Nelson David M, McBryan Tony, Jeyapalan Jessie C, Sedivy John M, Adams Peter D
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Age (Dordr). 2014 Jun;36(3):9637. doi: 10.1007/s11357-014-9637-0. Epub 2014 Mar 20.
Cellular senescence is a stable proliferation arrest associated with an altered secretory pathway, the senescence-associated secretory phenotype. However, cellular senescence is initiated by diverse molecular triggers, such as activated oncogenes and shortened telomeres, and is associated with varied and complex physiological endpoints, such as tumor suppression and tissue aging. The extent to which distinct triggers activate divergent modes of senescence that might be associated with different physiological endpoints is largely unknown. To begin to address this, we performed gene expression profiling to compare the senescence programs associated with two different modes of senescence, oncogene-induced senescence (OIS) and replicative senescence (RS [in part caused by shortened telomeres]). While both OIS and RS are associated with many common changes in gene expression compared to control proliferating cells, they also exhibit substantial differences. These results are discussed in light of potential physiological consequences, tumor suppression and aging.
Crit Rev Oncol Hematol. 2010-8-11
Aging (Albany NY). 2016-1
Adv Exp Med Biol. 2018
Methods Mol Biol. 2025
Front Biosci (Landmark Ed). 2012-6-1
Exp Gerontol. 2001-4
Curr Opin Cell Biol. 2012-11-2
Adv Sci (Weinh). 2024-1
Front Aging. 2021-7-6
Oncol Lett. 2021-7
Genes Dev. 2014-1-15
Development. 2013-8
Aging (Albany NY). 2012-11
Mol Biol Cell. 2012-4-11
Genes Dev. 2011-12-8
Ageing Res Rev. 2010-12-8